Save your place

Sign in to WhoBought

Please try again later.

Regeneron Pharmaceuticals, Inc. (REGN) institutional ownership

Latest close $675.19 Jul 21, 2026
Market cap$68.7B 52-week range SectorHealthcare
Funds holding · Q1 2026
1,257
reported REGN position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Net sold $1.1B
694 buyers · 563 sellers

Regeneron Pharmaceuticals, Inc. (REGN) price and institutional activity

Dates

Q1 2026

$5.1B bought by 694 investors
Wellington Management Group LLP$898MTwo Sigma Investments, LP$407M +692 more
$6.2B sold by 563 investors
Norges-$1.0BFMR LLC-$614M +561 more
Bought Sold Totals per quarter; hover a bar for the names.

Regeneron Pharmaceuticals, Inc. (REGN) institutional activity · 1,257

Investor Type Est. change Change Δ Own Date
Norges · Exited −$1.0B
Change −1.3M Δ Own −100.0% Date Q1 2026
Norges Exited· Q1 2026 −$1.0B −1.3M −100.0% Q1 2026
Wellington Management Group LLP · Added +$898M
Change +1.2M Δ Own +176.5% Date Q1 2026
Wellington Management Group LLP Added· Q1 2026 +$898M +1.2M +176.5% Q1 2026
FMR LLC · Reduced −$614M
Change −801K Δ Own −34.5% Date Q1 2026
FMR LLC Reduced· Q1 2026 −$614M −801K −34.5% Q1 2026
Two Sigma Advisers, LP · Exited −$463M
Change −605K Δ Own −100.0% Date Q1 2026
Two Sigma Advisers, LP Exited· Q1 2026 −$463M −605K −100.0% Q1 2026
Two Sigma Investments, LP · Added +$407M
Change +531K Δ Own +188.9% Date Q1 2026
Two Sigma Investments, LP Added· Q1 2026 +$407M +531K +188.9% Q1 2026
Marshall Wace, LLP · Reduced −$366M
Change −478K Date Q1 2026
Marshall Wace, LLP Reduced· Q1 2026 −$366M −478K Q1 2026
Holocene Advisors, LP · Exited −$353M
Change −461K Δ Own −100.0% Date Q1 2026
Holocene Advisors, LP Exited· Q1 2026 −$353M −461K −100.0% Q1 2026
Pacer Advisors, Inc. · Exited −$304M
Change −398K Δ Own −100.0% Date Q1 2026
Pacer Advisors, Inc. Exited· Q1 2026 −$304M −398K −100.0% Q1 2026
JPMorgan Chase & Co · Added +$285M
Change +372K Date Q1 2026
JPMorgan Chase & Co Added· Q1 2026 +$285M +372K Q1 2026
Vanguard · Added +$251M
Change +327K Date Q1 2026
Vanguard Added· Q1 2026 +$251M +327K Q1 2026
Millennium Management LLC · Reduced −$243M
Change −317K Date Q1 2026
Millennium Management LLC Reduced· Q1 2026 −$243M −317K Q1 2026
Acadian Asset Management LLC · Reduced −$226M
Change −295K Date Q1 2026
Acadian Asset Management LLC Reduced· Q1 2026 −$226M −295K Q1 2026
Bellevue Group AG · Added +$203M
Change +265K Date Q1 2026
Bellevue Group AG Added· Q1 2026 +$203M +265K Q1 2026
Point72 Asset Management, L.P. · Reduced −$199M
Change −260K Δ Own −99.2% Date Q1 2026
Point72 Asset Management, L.P. Reduced· Q1 2026 −$199M −260K −99.2% Q1 2026
AQR Capital Management LLC · Added +$180M
Change +235K Date Q1 2026
AQR Capital Management LLC Added· Q1 2026 +$180M +235K Q1 2026
Data through Q1 2026 · filed Jun 11, 2026
15 of 1257

Famous investor activity in Regeneron Pharmaceuticals, Inc. (REGN)

Regeneron Pharmaceuticals, Inc. (REGN) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Ryan Arthur F. · Director Sell −$130K
Price $650.15 Qty −200 Owned 17K ΔOwn −1.1% Trade date Jul 2, 2026 Filed date Jul 7, 2026
Ryan Arthur F. Director Sell $650.15 −200 −$130K 17K −1.1% Jul 2, 2026 Jul 7, 2026
Ryan Arthur F. · Director 12 operations −$71K
Price $701.76–$714.13 Qty −100 Owned 18K Trade date May 1, 2026 Filed date May 4, 2026
Ryan Arthur F. Director 12 operations $701.76–$714.13 −100 −$71K 18K May 1, 2026 May 4, 2026
Ryan Arthur F. · Director 9 operations −$78K
Price $771.32–$779.71 Qty −100 Owned 18K Trade date Apr 1, 2026 Filed date Apr 3, 2026
Ryan Arthur F. Director 9 operations $771.32–$779.71 −100 −$78K 18K Apr 1, 2026 Apr 3, 2026
Ryan Arthur F. · Director 13 operations −$79K
Price $777.46–$789.28 Qty −100 Owned 18K Trade date Mar 2, 2026 Filed date Mar 3, 2026
Ryan Arthur F. Director 13 operations $777.46–$789.28 −100 −$79K 18K Mar 2, 2026 Mar 3, 2026
Zoghbi Huda Y. · Director 11 operations −$1.3M
Price $774.68–$790.00 Qty −2K Owned 3K Trade date Feb 19, 2026 Filed date Feb 23, 2026
Zoghbi Huda Y. Director 11 operations $774.68–$790.00 −2K −$1.3M 3K Feb 19, 2026 Feb 23, 2026
Zoghbi Huda Y. · Director 2 operations 0
Price $376.69 Owned 800 Trade date Feb 19, 2026 Filed date Feb 23, 2026
Zoghbi Huda Y. Director 2 operations $376.69 0 800 Feb 19, 2026 Feb 23, 2026
Pitofsky Jason · Officer 11 operations −$1.6M
Price $775.95–$785.72 Qty −2K Owned 5K Trade date Feb 9, 2026 Filed date Feb 11, 2026
Pitofsky Jason Officer 11 operations $775.95–$785.72 −2K −$1.6M 5K Feb 9, 2026 Feb 11, 2026
Pitofsky Jason · Officer 2 operations 0
Price $492.00 Owned 905 Trade date Feb 9, 2026 Filed date Feb 11, 2026
Pitofsky Jason Officer 2 operations $492.00 0 905 Feb 9, 2026 Feb 11, 2026
Ryan Arthur F. · Director 13 operations −$78K
Price $775.63–$787.82 Qty −100 Owned 18K Trade date Feb 9, 2026 Filed date Feb 11, 2026
Ryan Arthur F. Director 13 operations $775.63–$787.82 −100 −$78K 18K Feb 9, 2026 Feb 11, 2026
Bassler Bonnie L. · Director Sell −$1.2M
Price $800.00 Qty −2K Owned 2K Trade date Jan 7, 2026 Filed date Jan 8, 2026
Bassler Bonnie L. Director Sell $800.00 −2K −$1.2M 2K Jan 7, 2026 Jan 8, 2026
Bassler Bonnie L. · Director 2 operations 0
Price $374.12 Owned 3K Trade date Jan 7, 2026 Filed date Jan 8, 2026
Bassler Bonnie L. Director 2 operations $374.12 0 3K Jan 7, 2026 Jan 8, 2026
Zoghbi Huda Y. · Director 2 operations 2K
Owned 2K Trade date Jan 2, 2026 Filed date Jan 6, 2026
Zoghbi Huda Y. Director 2 operations 2K 2K Jan 2, 2026 Jan 6, 2026
Thompson Craig B. · Director 2 operations 2K
Owned 2K Trade date Jan 2, 2026 Filed date Jan 6, 2026
Thompson Craig B. Director 2 operations 2K 2K Jan 2, 2026 Jan 6, 2026
Sing George L. · Director 2 operations 2K
Owned 2K Trade date Jan 2, 2026 Filed date Jan 6, 2026
Sing George L. Director 2 operations 2K 2K Jan 2, 2026 Jan 6, 2026
Guarini Kathryn · Director 2 operations 2K
Owned 2K Trade date Jan 2, 2026 Filed date Jan 6, 2026
Guarini Kathryn Director 2 operations 2K 2K Jan 2, 2026 Jan 6, 2026
15 of 58
15 of 58 Sign in to continue to older insider transactions.

Regeneron Pharmaceuticals, Inc. (REGN) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
FMR LLC 10.3M
% of shares outstanding 9.6% Filing date Feb 9, 2024
FMR LLC 10.3M 9.6% Feb 9, 2024
Vanguard Group Inc 8.8M
% of shares outstanding 8.2% Filing date Feb 13, 2024
Vanguard Group Inc 8.8M 8.2% Feb 13, 2024
BlackRock Inc. 8.6M
% of shares outstanding 8.1% Filing date Jan 25, 2024
BlackRock Inc. 8.6M 8.1% Jan 25, 2024
Vanguard Capital Management 7.7M
% of shares outstanding 7.4% Filing date Apr 30, 2026
Vanguard Capital Management 7.7M 7.4% Apr 30, 2026
JPMorgan Chase & Co 7.2M
% of shares outstanding 6.7% Filing date Jan 25, 2024
JPMorgan Chase & Co 7.2M 6.7% Jan 25, 2024
Capital World Investors 5.2M
% of shares outstanding 4.8% Filing date Feb 9, 2024
Capital World Investors 5.2M 4.8% Feb 9, 2024
6 of 6

Regeneron Pharmaceuticals, Inc. (REGN) ownership FAQ

Who owns REGN?

1,257 reporting institutions disclosed REGN position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.